Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients

Clinical trial NCT03246009 · COMPLETED

Trial details

NCT number: NCT03246009
Sponsor: Tianjin SinoBiotech Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia Cancer, Breast

Start date: 2016-01-21
Primary completion: 2017-04-10
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.